Case Reports in Gastrointestinal Medicine
Volume 2018 (2018), Article ID 2496193, 7 pages
https://doi.org/10.1155/2018/2496193

Case Report

Unexplained Portal Gas in a Patient with an Esophageal Ulcer

Samiksha Gupta,¹ Balaram Krishna Surapaneni,² Rakesh Vinayek,¹ and Sudhir K. Dutta¹

¹Sinai Hospital, Baltimore, Maryland, USA
²Aventura Hospital and Medical Center, Aventura, Florida, USA

Correspondence should be addressed to Sudhir K. Dutta; sudhirdutta100@gmail.com

Received 23 July 2018; Revised 20 September 2018; Accepted 1 November 2018; Published 10 December 2018

Academic Editor: Yoshihiro Moriwaki

Copyright © 2018 Samiksha Gupta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Emphysematous gastritis is the infection of gastric mucosa by gas producing microorganisms. It is a rare infection with less than 100 cases reported in the literature. The association of portal venous gas along with emphysematous gastritis is a rare entity. The concomitant portal venous gas worsens the outcome and warrant for surgical treatment. Our case has portal venous gas on CT scan along with suspicion of emphysematous gastritis and an esophageal ulcer on upper GI endoscopy. Medical treatment was given in our case of portal venous gas with the esophageal ulcer. Our case is unique because our patient responded to the conservative management. The patient presented with past history of polysubstance abuse and chronic kidney disease presented with symptoms of acute abdomen. CT scan revealed portal venous gas and suspicion of gastric emphysema. In addition, few foci of gas are seen along the vessels traversing between the stomach and liver. Endoscopy with gastric mucosa biopsy showed Candida albicans. Subsequently, antifungals were started. There was improvement in clinical condition of the patient. We, hereby, also summarize all the reported cases of emphysematous gastritis with treatment and outcome in each case. There has been change in trend from surgical to medical treatment.

1. Introduction

Emphysematous gastritis (EG) is a polymicrobial infection of gastric mucosa that is caused predominantly by gas producing bacteria. Though EG is a rare condition with a handful of cases reported, it is associated with a poor prognosis. In addition, the presence of portal venous gas in individuals with EG further worsens the outcome. Until recent years, surgery has been the main modality of treatment for emphysematous gastritis, especially in patients with associated portal venous gas. However, there has been a change in trend from the surgical management to a more conservative approach because of the postsurgical complications and insignificant difference in long-term prognosis between two approaches.

Herein, we report a case of a middle aged male with past medical history of polysubstance abuse and chronic kidney disease who was suspected of emphysematous gastritis with associated portal venous gas. Our case report is unique because our patient responded adequately to the conservative treatment despite the associated portal venous gas.

2. Patient Information

A 48-year-old man with past medical history of COPD on home oxygen, chronic anemia, remote history of polysubstance abuse and alcohol abuse, tobacco use, and chronic kidney disease, PUD gastritis, and GI bleeding, presented to our hospital with complaints of fever, sudden onset nausea, abdominal pain, and hematemesis for 3 days.

3. Clinical Findings

On physical examination, his abdomen was distended and there was tenderness on palpation over the epigastrium, right and left upper quadrants but without any guarding and rebound tenderness. In addition, the bowel sounds were hypoactive. His vital signs were unremarkable apart from mild tachycardia.

4. Timeline

Acute onset of pain with upper GI bleeding was suggestive of borderline features of acute abdomen.

5. Diagnostic Assessment

Our patient’s CBC with hemoglobin of 7 mg/dl and hematocrit of 27.6% was diagnostic of anemia and leukocytosis with WBC count of 16.04 ×10⁹/L. His basic metabolic panel was significant for deranged kidney functions and electrolyte disturbances with elevated creatinine (1.97 mg/dl) and BUN (30 mg/dl), mild hypokalemia (3.2mEq/L), and hyperphosphatemia (8mg/dl). LFTs and lactate were within normal range. Furthermore, his CT scan revealed irregular thickened distal esophagus with markedly distended stomach (probably secondary to gastric outlet obstruction) as well as portal venous gas. There was suspicion of limited gastric emphysema as well. In addition, few foci of gas are seen along the vessels traversing between the stomach and liver (Figure 1).

Figure 1: Abdominal CT scan showing stomach distension and limited gas within the wall of the stomach and in the portal venous system.

6. Therapeutic Intervention

In view of the suspicion of emphysematous gastritis, our patient was kept nil by mouth, had an NGT decompression, and was initiated on intravenous PPIs. Also, intravenous piperacillin-tazobactam was added for the broad spectrum coverage against gram-negative bacteria and anaerobes. For his severe anemia, he was given a unit of blood and his hemoglobin/hematocrit monitored 6 hourly. The patient had a repeat CT scan on the 5th day of admission which showed partial resolution of the gas on the CT scan. (Figure 2). On the 7th day of admission, he had an upper GI endoscopy which was suggestive for nonbleeding erosive gastropathy, erythematous mucosa in the gastric body and antrum, esophagitis, nonbleeding esophageal ulcer (Figure 3). However, there were no gross findings suggestive of ischemia or necrosis. During the endoscopy, a biopsy was taken from the fundus, body, antrum of the stomach and distal esophagus. The biopsy histology was evident for mild chronic gastritis and there was the growth of Candida albicans in the culture. Our patient was started on intravenous fluconazole to which he responded well with improvement in his symptoms.

Figure 2: CT scan of the abdomen on the 5th day of admission showing resolution of air in the stomach wall and portal venous gas.

Figure 3: Endoscopy images showing nonbleeding erosive gastropathy, erythematous mucosa in the gastric body and antrum, esophagitis, and nonbleeding esophageal ulcer (7th day of admission).

7. Follow-Up and Outcomes

Patient was followed up after 6 months and was asymptomatic.

8. Discussion

Emphysematous gastritis is a not so common entity with less than hundred cases reported till now on pubmed search. Emphysematous gastritis occurs when the gas producing microorganisms invade the wall of stomach and ferment glucose to produce gases like carbon dioxide (CO₂) and nitrogen (N₂). Clostridium, Streptococci, Staphylococcus, E. coli and Pseudomonas species, Candida and mucor constitute the group of organisms responsible for infection in EG [1]. A recent case report also mentions about the association of a rare gram-positive coccus, Sarcina ventriculi [2]. Although the Candida was detected in gastric mucosa biopsy in our case, it is difficult to mention that it is the causal agent as Candida is commonly associated with other comorbidities like CKD and immunosuppression. Gas chromatography has been done to find the type of gases in pneumatosis intestinalis; however, it has not been done in cases of emphysematous gastritis. Levitt MD et al. found that the intraluminal gas in intestine is the swallowed air by demonstrating the intraluminal gas composition similar to that of atmospheric air with predominantly nitrogen and oxygen less than 2 % [3]. However, the intramural gas composition in upper GI tract is unknown although it is clear that methane, hydrogen, and hydrogen sulphide found in cases of pneumatosis intestinalis are produced by bacteria in the intestine. These gases are not found in the atmospheric air in the same composition.

Ingestion of corrosives, alcohol abuse, recent surgery, compromise of blood supply due to atherosclerosis and other comorbidities like end-stage renal disease, peptic ulcer disease, diabetes mellitus, malnutrition, NSAIDs, and steroid use are certain factors that increase the risk of infection in gastric mucosa. In addition, hydrogen peroxide [4], AIDS [5], coxsackie B3 myocarditis [6], breast cancer [7], severe vomiting [8], and blunt abdominal trauma [9] have also been reported to be predisposing factors for EG. Our patient had a history of polysubstance abuse, smoking, hyperlipidemia, history of chronic kidney disease, and chronic anemia, which could precipitate emphysematous gastritis.

Diagnosis of emphysematous gastritis can be made on the basis of clinical features and characteristic findings on imaging. Clinically, in addition to acute abdomen symptoms of pain, nausea, or vomiting, EG also presents with fever, neurologic changes, and hemodynamic instability [10, 11]. Nonetheless, there can be a less dramatic presentation of emphysematous gastritis in patients with immunocompromised status like those of diabetes mellitus, end-stage renal disease, and cirrhosis [12]. The pathognomic finding of EG is emesis of the necrotic mucosal clot in the shape of the gastric wall that is due to dissection of the muscularis mucosa by bacterial organisms [13]. Clinical findings are mostly nonspecific in case of emphysematous gastritis. Therefore, radiological imaging plays an important role in the diagnosis of EG. Plain film shows distended stomach with thickened gastric folds due to edema along with innumerable gas bubbles in mottled distribution. CT scan is more sensitive compared to the plain films and is the modality of choice for making the diagnosis of EG [14]. With increasing use of CT scan worldwide, there is increase in the incidence and the prevalence of this entity. On CT scan, EG is characterised by the presence of gas bubbles in irregular pattern along the wall of stomach, thickening of gastric mucosal folds with or without portal venous gas [15]. Concomitant small bowel or colonic pneumatosis found on CT scan worsens the prognostic outcome [16]. Our patient was hemodynamically stable with worse CT scan findings compared to his clinical presentation. The CT scan showed portal venous gas and suspicion of gas within the gastric wall. Entry of gas in venous system occurs due to necrosis of bowel from infection, inflammation or rise in the intraluminal pressure [17]. Thus, presence of portal venous gas in patients with EG signifies poor prognosis [18]. In a study by Liebman et al., portal vein gas is associated with 75% mortality and almost all patients require surgery [19]. Due to severe abdominal pain and hematemesis with bubbly irregular air in the gastric wall without any history of mechanical trauma to abdomen, our case was suggestive of emphysematous gastritis. Radiologically, this case is unique because our patient responded well to adequate treatment despite the presence of portal vein gas. Very few cases of gastric emphysema with portal venous gas have been reported in the literature which responded to the conservative management [17, 20].

Due to the rare occurrence of disease, there are no established guidelines for diagnosis and management of emphysematous gastritis. During the past decades, patients used to present in advanced stage of emphysematous gastritis with ischemic and necrotic changes of gastric mucosa, peritonitis, and hemodynamic instability [22]. In such cases, gastrectomy or partial gastrectomy was considered as the treatment modality. Surgical intervention can be considered depending on presentation, hemodynamic status, age, comorbidities, the extent of bowel involvement, complications such as perforation of bowel, peritonitis, and necrotic bowel. The surgical intervention is usually associated with poor and unsatisfactory outcome especially in the setting of associated comorbidities [42]. In addition, there can be postsurgical complications including anastomotic breakdown and leakage, development of fistulae, and chronic stricture formation. There is 60%-80% mortality rate of patients with emphysematous gastritis despite early aggressive treatment [21]. Endoscopy with biopsy and culture of gastric mucosa and supportive medical treatment is preferred over surgical treatment because of the higher mortality rate associated with surgical interventions. Therefore, surgical management can be considered only when the conservative management fails. Matsushima K et al. listed the treatment and the outcome of 39 case reports published from 1980-2012 [10]. Further, we have added 28 cases of EG from 2012 until today (Table 1). On reviewing the literature, it is revealed that the rate of reporting has increased from 39 cases in 32 years (1980-2012) to 26 cases in 5 years (2013-2018). It is certain that the rate of reporting has quadrupled after 2012. This could perhaps the result of increased application of CT scan early on during the patient evaluation and increased sensitivity of CT scan for detection of intramural gas with technological enhancement. Although the diagnosis is suspected based on clinical features which are nonspecific, the actual diagnosis is made by radiological findings on CT scan. Increased application of CT scan in making diagnosis not only increased the rate of reporting but has also resulted in increased survival of EG patients due to early diagnosis. 20 out of 39 patients died from in 32 years (1980-2012) whereas 4 out of 28 cases died in 5 years (2013-2018). The increased survival could also be the result of early intervention in the form of broad spectrum antibiotics.

Table 1: Treatment and outcome of cases of EG (1980 -2018).

Year
Author
Surgery
Isolated organism
Outcome

1982
Williford et al.
No
Strongyloides stercoralis
Dead

1986
de Lange et al.
No
Gram-positive cocci
Dead

1987
Bloodworth et al.
No
Klebsiella pneumoniae, Streptococcus
Dead

1989
Williamson et al.
Exploratory laparotomy
Candida spp.
Dead

1989
Monteferrante et al.
NA
Group D enterococci, E. coli
Dead

1990
Caruana et al.
No
Peritoneal fluid: Torulopsis glabrate, stomach biopsy: mixed gram negatives
Alive

1990
Moosvi et al.
Subtotal gastrectomy
Enterobacter aerogenes, Enterobacter, candida, pseudomonas
Alive

1992
Binmoeller et al.
No
Clostridium welchii
Dead

1994
McKelvie et al.
No
Gram-positive cocci, gram-positive rods
Dead

1995
Van Allan et al.
Total gastrectomy
Streptococcus viridans, yeast, fungi
Alive

1995
Lin et al.
Total gastrectomy
Klebsiella pneumonia, E. coli,
Alive

1996
Sud et al.
No
E. coli
Dead

1998
Bashour et al.
Exploratory laparotomy
Clostridium perfringens, yeast
Dead

1999
Cherney et al.
Total gastrectomy
Stomach pathology: mucormycosis, peritoneal fluid: Yersinia, Enterobacter
Dead

2001
Shipman et al.
No
Enterococcus spp
Alive

2002
Wong et al.
No
NA
Dead

2002
Van Mook et al.
No
Klebsiella pneumonia, Candida albicans
Dead

2002
Ho DC et al.
No
NA
Dead

2003
Yalamanchili et al.
Total gastrectomy
Candida glabrata, Candida krusei
Dead

2003
Gutierrez et al.
No
NA
Alive

2003
Buyl et al.
Exploratory laparotomy
Pseudomonas aeruginosa, Streptococcus
NA

2004
Ocepek et al.
Cholecystectomy
Clostridium difficile
Dead

2005
Allan et al.
No
None
Alive

2006
Abboud et al.
Exploratory laparotomy
NA
Dead

2006
Iqbal et al. [21]
No
NA
Alive

2007
Loi et al.
No
Pseudomonas spp, Acinetobacter spp
Alive

2007
Carlson et al.
No
None
Alive

2007
Lee et al.
No
Enterobacter cloacae
Dead

2007
Jung et al.
Total gastrectomy
Stomach pathology: Mucormycosis
Dead

2008
Al-Jundi et al. [13]
No
Gastric aspirate: Klebsiella pneumoniae
Alive

2009
Huang et al. [22]
Total gastrectomy
Blood/peritoneal fluid: E. coli
Dead

2009
Agarwal et al.
Total gastrectomy
NA
Dead

2010
Schorn et al.
No
None
Alive

2010
Dawwas et al.
No
Gastric mucosa: Candida glabrata
Alive

2010
Paul M et al.
No
Streptococcus viridans
Alive

2011
Arezzo et al.
No
NA
Alive

2011
Hassan et al.
No
None
Alive

2012
Ferrada
Wedge resection of stomach
NA
Alive

2012
Matsushima K et al. [10]
Exploratory laparotomy
None
Alive

2012
Ng A et al. [23]
No
NA
Alive

2012
X. Verhelst et al. [24]
Subtotal gastrectomy
Candida albicans
Alive

2013
Yu HH et al. [25]
Exploratory laprotomy
Klebsiella pneumoniae
Alive

2013
Wormer BA et al. [26]
No
NA
Alive

2013
Szuchmacher M et al [27]
Exploratory laparotomy
NA
Alive

2013
Ratuapli et al. [28]
No
Sarcina ventriculi
Alive

2013
Nair et al. [29]
No
NA
Alive

2014
Murchie et al. [30]
No
NA
Alive

2014
Yusef et al. [31]
No
None
Alive

2014
A Misro [32]
No
NA
Alive

2015
Alvarado-Lezama J et al. [33]
Total gastrectomy
Mucor
Alive

2015
F. Uysal et al. [34]
No
Gram-positive anaerobic spore-forming bacillus
Alive

2015
Takano et al. [35]
No
Escherichia coli and Enterococcus avium
Alive

2015
Matsunaga et al. [7]
No
NA
Dead

2015
Guillén-Morales C et al. [36]
No
NA
Dead

2016
Zamora Elson M et al. [37]
No
H. pylori
Alive

2016
Ashfaq et al. [6]
No
NA
Dead

2016
Jehangir A et al. [38]
No
NA
alive

2016
Sharma et al. [39]
No
NA
Alive

2016
Sarvari KP et al. [40]
No
Gram positive thick rods: clostridium
Dead

2016
Sulaimani M et al. [11]
No
NA
Unknown

2017
Nehme F et al. [41]
No
NA
Alive

2017
Yao J et al. [5]
No
None
Alive

2017
Li K et al. [4]
No
NA
Alive

2018
Alvin M et al. [2]
Exploratory laprotomy
Sarcina ventriculi
Alive

2018
Kyawzaw L et al. [42]
No
NA
Alive

2018
Gardenyes J et al. [43]
No
NA
Dead

2018
Our case
No
Candida albicans
Alive

Gas within gastric wall could be of two origins. It could be intraluminal air dissecting the wall of stomach that occurs in case of gastric emphysema. Secondly, gas could be produced by fermentation process of bacteria or fungi like that in case of emphysematous gastritis [44]. Gastric emphysema is another condition that should be differentiated from emphysematous gastritis. Gastric emphysema is a clinical entity that occurs when the intraluminal air invades the wall of stomach secondary to traumatic (endotracheal intubation/ nasogastric tube placement), mechanic (increase pressure in bowel lumen due to obstruction), or inflammatory (ingestion of corrosive substances, ischemia due to atherosclerosis) etiologies. In contrast to emphysematous gastritis, gastric emphysema has a benign course with no evidence of infection. Matsushima K et al. compared clinical presentation of 39 cases of emphysematous gastritis with that of 36 cases of gastric emphysema where they concluded that features of infection and systemic toxicity were associated with emphysematous gastritis only [10]. EG requires antimicrobials whereas gastric emphysema is treated conservatively with self-resolution. In our case, the gastric biopsy sample showed the growth of Candida albicans and he responded well to antifungals.

Consent

Informed consent was taken from the patient.

Disclosure

The authors whose names are listed in the first page certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

A. Watson, V. Bul, J. Staudacher, R. Carroll, and C. Yazici, “The predictors of mortality and secular changes in management strategies in emphysematous gastritis,” Clinics and Research in Hepatology and Gastroenterology, vol. 41, no. 1, pp. e1–e7, 2017.

M. Alvin and N. Al Jalbout, “Emphysematous gastritis secondary to,” BMJ Case Reports, p. bcr-2018-224233.

M. D. Levitt, “Volume and composition of human intestinal gas determined by means of an intestinal washout technic,” The New England Journal of Medicine, vol. 284, no. 25, pp. 1394–1398, 1971.

K. Li, D. Shepherd, and C. G. Smollin, “Emphysematous esophagitis and gastritis due to ingestion of concentrated hydrogen peroxide,” The Journal of Emergency Medicine, vol. 54, no. 3, pp. e53–e54, 2018.

J. Yao, J. Morgan, and J. Brotman, “Air in the gastric wall of a patient with AIDS,” Radiology Case Reports, vol. 12, no. 3, pp. 491–493, 2017.

A. Ashfaq and A. B. Chapital, “Emphysematous gastritis in a patient with coxsackie B3 myocarditis and cardiogenic shock requiring veno-arterial extra-corporeal membrane oxygenation,” International Journal of Surgery Case Reports, vol. 14, pp. 121–124, 2015.

M. Matsunaga, T. Fujii, T. Ushijima, and K. Miwa, “Emphysematous gastritis in a patient with breast cancer,” Internal Medicine, vol. 54, no. 13, pp. 1667-1668, 2015.

M. P. Parikh, M. Sherid, V. Ganipisetti, V. Gopalakrishnan, M. Habib, and M. Tripathi, “Vomiting-induced gastric emphysema and hepatoportal venous gas: A case report and review of the literature,” Case Reports in Medicine, vol. 2015, 4 pages, 2015.

I. Sen, I. Samarasam, S. Chandran, and G. Mathew, “Gastric intramural and portal venous gas following blunt injury abdomen,” Archives of Trauma Research, vol. 2, no. 2, pp. 95-96, 2013.

K. Matsushima, E. J. Won, M. R. Tangel, L. M. Enomoto, D. M. Avella, and D. I. Soybel, “Emphysematous gastritis and gastric emphysema: Similar radiographic findings, distinct clinical entities,” World Journal of Surgery, vol. 39, no. 4, pp. 1008–1017, 2015.

M. Sulaimani, A. R. Alshehri, M. Hmoud, N. Waggas, and G. Aboalsamh, “Emphysematous gastritis: a case report,” International Journal of Scientific Reports, vol. 3, no. 1, p. 19, 2016.

S. A. Fidvi and S. A. Klein, “Radiological case of the month-Clinical Quiz,” Applied Radiology, vol. 31, no. 3, pp. 33–36, 2002.

W. Al-Jundi and A. Shebl, “Emphysematous gastritis: case report and literature review,” International Journal of Surgery, vol. 6, no. 6, pp. e63–e66, 2008.

D. E. Grayson, R. M. Abbott, A. D. Levy, and P. M. Sherman, “Emphysematous infections of the abdomen and pelvis: a pictorial review,” RadioGraphics, vol. 22, no. 3, pp. 543–561, 2002.

P. T. Johnson, K. M. Horton, B. H. Edil, E. K. Fishman, and W. W. Scott, “Gastric pneumatosis: the role of CT in diagnosis and patient management,” Emergency Radiology, vol. 18, no. 1, pp. 65–73, 2011.

M. Spektor, V. Chernyak, T. E. McCann, and M. H. Scheinfeld, “Gastric pneumatosis: Laboratory and imaging findings associated with mortality in adults,” Clinical Radiology, vol. 69, no. 11, pp. e445–e449, 2014.

M. Paul, S. John, M. C. Menon, N. H. Golewale, S. L. Weiss, and U. K. Murthy, “Successful medical management of emphysematous gastritis with concomitant portal venous air: A case report,” Journal of Medical Case Reports, vol. 4, 2010.

I. Rankin and H. Sheth, “Hepatic portal venous gas: comparison of two cases,” Case Reports in Surgery, vol. 2013, Article ID 637951, 5 pages, 2013.

P. R. Liebman, M. T. Patten, J. Manny, J. R. Benfield, and H. B. Hechtman, “Hepatic-portal venous gas in adults: Etiology, pathophysiology and clinical significance,” Annals of Surgery, vol. 187, no. 3, pp. 281–287, 1978.

A. Hussain, H. Mahmood, and S. El-Hasani, “Portal vein gas in emergency surgery,” World Journal of Emergency Surgery, vol. 3, no. 1, article 21, 2008.

M. Iqbal, O. Ishtiaq, A. Akhtar, Y. Chaudery, and B. Khizar, “Empysematous gastritis - A case report with literature review,” Journal of the Pakistan Medical Association, vol. 56, no. 12, pp. 605–607, 2006.

C.-T. Huang and W.-Y. Liao, “Emphysematous gastritis: A deadly infectious disease,” Infectious Diseases, vol. 41, no. 4, pp. 317–319, 2009.

A. Ng, M. Spanger, and J. Lubel, “Hepatobiliary and Pancreatic: Emphysematous gastritis with hepatic portal venous gas,” Journal of Gastroenterology and Hepatology, vol. 27, no. 6, p. 1130, 2012.

X. Verhelst, M. Cabooter, V. De Wilde, P. Laukens, and H. Orlent, “A case of emphysematous gastritis,” Endoscopy, vol. 44, no. 2, p. E159, 2012.

H. H. Y. Yu, S. Tsang, T. T. Cheung, and C. M. Lo, “Surviving emphysematous gastritis after hepatectomy,” Case Reports in Hepatology, vol. 2013, Article ID 106383, 4 pages, 2013.

B. A. Wormer and G. Mostafa, “Emphysematous gastritis with delayed gastric perforation,” Journal of Gastrointestinal Surgery, vol. 17, no. 7, pp. 1336–1338, 2013.

M. Szuchmacher, T. Bedford, P. Sukharamwala, M. Nukala, N. Parikh, and P. Devito, “Is surgical intervention avoidable in cases of emphysematous gastritis? A case presentation and literature review,” International Journal of Surgery Case Reports, vol. 4, no. 5, pp. 456–459, 2013.

S. K. Ratuapli, D. M. Lam-Himlin, and R. I. Heigh, “Sarcina ventriculi of the stomach: A case report,” World Journal of Gastroenterology, vol. 19, no. 14, pp. 2282–2285, 2013.

R. Nair, S. Agrawal, and B. Nayal, “Spontaneous resolution of emphysematous gastritis with vaso-occlusive disease-a case report,” Malaysian Journal of Medical Sciences, vol. 20, no. 3, pp. 68–70, 2013.

B. Murchie, “Emphysematous gastritis: an ominous diagnosis managed conservatively,” ACG Case Reports Journal, vol. 1, no. 3, pp. 120-121, 2014.

D. Yusef, A. Waran, and E. Vamvakiti, “A 16-year-old boy with emphysematous gastritis and oesophageal candidiasis,” BMJ Case Reports, vol. 2014, 2014.

A. Misro and H. Sheth, “Diagnostic dilemma of gastric intramural air,” Annals of the Royal College of Surgeons of England, vol. 96, no. 7, pp. e11–e13, 2014.

J. Alvarado-Lezama, O. Espinosa-González, E. García-Cano, and G. Sánchez-Córdova, “Emphysematous gastritis secondary to gastric mucormycosis,” Cirugía y Cirujanos (English Edition), vol. 83, no. 1, pp. 56–60, 2015.

F. Uysal, E. Akbal, F. Günes, S. Saçar, and H. Özdemir, “An unusual and serious cause of gastritis: Emphysematous gastritis,” Diagnostic and Interventional Imaging, vol. 96, no. 3, pp. 291-292, 2015.

Y. Takano, E. Yamamura, K. Gomi et al., “Successful conservative treatment of emphysematous gastritis,” Internal Medicine, vol. 54, no. 2, pp. 195–198, 2015.

C. Guillén-Morales, F. J. Jiménez-Miramón, T. Carrascosa-Mirón, and J. M. Jover-Navalón, “Emphysematous gastritis associated with portal venous gas: Medical management to an infrequent acute abdominal pain,” Revista Española de Enfermedades Digestivas, vol. 107, no. 7, pp. 455-456, 2015.

M. Z. Elson, L. L. Monzón, J. E. Orta, P. C. Fierro, V. V. Monteverde, and C. S. Arbeloa, “Emphysematous gastritis: Effectiveness of early antibiotic therapy,” Gastroenterología y Hepatología, vol. 39, no. 6, pp. 393–395, 2016.

A. Jehangir, A. Rettew, B. Shaikh, K. Bennett, A. Qureshi, and Q. Jehangir, “A case report of emphysematous gastritis in a diabetic patient: favorable outcome with conservative measures,” Journal of Community Hospital Internal Medicine Perspectives (JCHIMP), vol. 5, no. 4, p. 28010, 2015.

P. Sharma and E. G. Akl, “A combination of intramural stomach and portal venous air: conservative treatment,” Journal of Community Hospital Internal Medicine Perspectives (JCHIMP), vol. 6, no. 1, p. 30519, 2016.

K. P. Sarvari, B. Vasas, I. Kiss et al., “Fatal Clostridium perfringens sepsis due to emphysematous gastritis and literature review,” Anaerobe, vol. 40, pp. 31–34, 2016.

F. Nehme, K. Rowe, and I. Nassif, “Emphysematous gastritis with hepatic portal venous gas: A shift towards conservative management,” BMJ Case Reports, vol. 2017, 2017.

K. Lin, “Case series: gastric emphysema and emphysematous gastritis with air in portal venous system,” Gastroenterology & Hepatology: Open Access, vol. 9, no. 1, 2018.

J. Gardenyes, J. Hermoso, Y. Curbelo et al., “Gastric pneumatosis associated to portal venous gas: an image of emphysematous gastritis,” Surgery, vol. 164, no. 2, pp. 370-371, 2018.

G. López-Medina, R. Castillo Díaz de León, A. C. Heredia-Salazar, and D. R. Hernández-Salcedo, “Gastric emphysema a spectrum of pneumatosis intestinalis: a case report and literature review,” Case Reports in Gastrointestinal Medicine, vol. 2014, Article ID 891360, 5 pages, 2014.